Argonaute RNA

United Kingdom
Bristol, England, United Kingdom, BS8 1AS

Company profile

Argonaute RNA company profile

Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. Argonaute RNA research projects build on existing intellectual property. They show how their proprietary modification of small interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
BS8 1AS
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$2.3M
Last funding
Series Unknown / $2.3M / 2024-07-17
Last equity funding
Series Unknown / $2.3M
Investors
4
Lead investors
1
Articles
9

Founders and investors

Lead investors

Development Bank of Wales

Investors

Bristol Private Equity ClubDevelopment Bank of WalesEmpirical VenturesThe Fink Family Office